Trial Profile
A Study to Evaluate the Clinical Outcomes With Tenofovir (TDF) Use in ART in ART Naive HIV Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Apr 2016
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 22 Apr 2016 New trial record
- 25 Feb 2016 Results presented at the 23rd Conference on Retroviruses and Opportunistic Infections